EUVIMEDEUVIMED entdecken
Crossref

Optimizing the safety of chimeric antigen receptor T cell therapy — current strategies and future direction

Anna E. Szymkiewicz, Filip M. Walczak, Sylwia Trzpiot, Stanisław S. Góźdź, Paweł Steckiewicz, Artur Kowalik

Nowotwory. Journal of Oncology · 26.02.2026 · 76 (1) · 45-53

DOI: 10.5603/njo.107794 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nowotwory. Journal of Oncology, online erschienen am 26.02.2026. Verfasst von Anna E. Szymkiewicz und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Szymkiewicz, A. E., Walczak, F. M., Trzpiot, S., Góźdź, S. S., Steckiewicz, P., & Kowalik, A. (2026). Optimizing the safety of chimeric antigen receptor T cell therapy — current strategies and future direction. Nowotwory. Journal of Oncology, 76(1), 45-53. https://doi.org/10.5603/njo.107794

Vancouver

Szymkiewicz AE, Walczak FM, Trzpiot S, Góźdź SS, Steckiewicz P, Kowalik A. Optimizing the safety of chimeric antigen receptor T cell therapy — current strategies and future direction. Nowotwory. Journal of Oncology. 2026;76(1):45-53. doi:10.5603/njo.107794

BibTeX
@article{Szymkiewicz2026,
  author = {Szymkiewicz, Anna E. and Walczak, Filip M. and Trzpiot, Sylwia and Góźdź, Stanisław S. and Steckiewicz, Paweł and Kowalik, Artur},
  title = {Optimizing the safety of chimeric antigen receptor T cell therapy — current strategies and future direction},
  journal = {Nowotwory. Journal of Oncology},
  year = {2026},
  volume = {76},
  number = {1},
  pages = {45--53},
  doi = {10.5603/njo.107794}
}
Kostenlos starten →